Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety Results; Mail-Order Ketamine May Come Under Scrutiny; Our Notes from PSYCH Symposium

This Week: Early Analysis of MindMed’s Phase 2 LSD for Anxiety Results UK’s First Commercial Psychedelic Research Facility Launches; Trials to Begin in August Mail-Order Ketamine Providers May Come Under Increased Scrutiny Our Notes from PSYCH Symposium “Psychedelic Patents are Broken Because the Patent System Is Broken” and more… On Wednesday morning, Professor Matthias Liechti and Dr.

Source